Table 5.
Wilcoxon’s test of Fugl-Meyer–Lower Extremity (FMA-LE) assessment in the EG.
| Clinical Assessment | Experimental Group | p-Value* | |
|---|---|---|---|
| T0 | T1 | ||
| Motor functioning lower extremity | 14.00 (10–17.7) | 15.5 (12.5–19.5) | 0.002 |
| Balance | 3.0 (2.2–3.7) | 4.0 (4.0–4.0) | <0.001 |
| Sensory functioning | 12.0 (10.0–12.0) | 12.0 (11.0–12.0) | 0.10 |
| Joint range of motion | 20.0 (16.5–20.0) | 20.0 (17.7–20.0) | 0.52 |
| Joint pain | 20.0 (20.0–20–0) | 20.0 (20.0–20–0) | 0.34 |
| Total | 17.5 (12.2–21.7) | 19.5 (16.5–24.5) | <0.001 |
* Statistical significances are in bold. The results are expressed as median (first and third quartiles). Legend: 10MWT: 10 Meters Walking Test, FAC: Functional Ambulation Classification, TS: Tinetti Scale, MAS: Modified Ashworth Scale, FIM: Functional Independence Measure, MSQoL Ph: Multiple Sclerosis Quality of Life of Physical Health Composite Score, and MSQoL MT: Multiple Sclerosis Quality of Life of Mental Health Composite Score.